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Abstract 
In this report we discuss the role of interferon regulatory factor 1 (IRF-1) in the regulation of omithine decarboxylase (ODC) transcription during 
IFNy human macrophage activation. We show that a binding sequence for the transcription factor IRF-1 is contained in the first intron of the human 
ODC gene (from nt +2711 to nt +2722) and we demonstrate that the level of expression of IRF-1 increases in human macrophages and in the human 
promonocytic ell line, U937, previously differentiated in monocyteslmacrophages by phorbol myristate acetate (PMA), after 2 h of IFNy stimulation. 
We also show that the hamster tk-ts13 cell line, stably transfected with the IRF-1 cDNA, over-expresses ODC. In addition, a specific complex was 
detected, by gel-shift assay after incubating a 20 bp double-stranded oligomer containing the binding sequence for IRF-1 with nuclear proteins 
extracted from human macrophages and from ~MA-differentiated) U937 cells stimulated with IFNy for 2 h. 
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1. Introduction 
The enzyme ornithine decarboxylase (ODC) is the key 
regulator of the synthesis of polyamines that are essential 
for cell growth and prolife~tion. Expression of this gene, 
which is sustained in rapidly proliferating cells, tran- 
siently increases upon stimulation by growth factors 
[l-3], but becomes constitutively activated during cell 
transformation induced by carcinogens [4,5], viruses [b 
81, or oncogenes 19-121. Moreover, ODC behaves like a 
protooncogene [13]. The role of polyamines does not 
seem to be restricted only to cell growth and prolifera- 
tion; in fact, it has been shown that cell differentiation 
and the function of terminally differentiated cells also 
involve the activation of ODC and the ambulation of 
polyamines [14]. In previous reports we have demon- 
strated that the stimulation of human monocytes and 
mouse macrophages with lipopolysaccharide (LPS), in- 
terferon-y (IFNy), and tumor necrosis factor (TNF) 
leads to ODC ambulation [15,16], and that the induc- 
tion of ODC gene expression followed by polyamine 
accumulation has a functional significance for human 
macrophage activation [16,17]. In 1992, by the differen- 
tial screening of a cDNA library prepared from lym- 
phokine-treated mouse macrophage-like Raw 264.7 
cells, Farber [18] identified 11 genes induced early in the 
response to macrophage-activating factors. One of these 
genes encodes for a transcription factor, interferon regu- 
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latory factor 1 (IRF-1), which regulates the expression 
of IFN-jI and some IFN-inducible genes [19-211. IRF-1 
is expressed upon IFNy macrophage activation [I 81. 
Since we also found that the activation of human macro- 
phages and U937 cells with IFNy leads to the expression 
of the IRF-1 gene, and that a consensus binding se- 
quence for IRF-1 is present in the first intron (non- 
coding region) of the ODC gene (from nt +2711 to nt+ 
2722) (Fig. I), we hypothesized that IRF-1 binds to this 
sequence in the ODC gene and regulates ODC expres- 
sion during IFNy macrophage activation. 
2. Materials and methods 
2. I. Cells and culture conditions 
Fresh human buffy coats were obtained from a blood bank and, after 
2-fold dilution with PBS supplemented with 2.5 mM EDTA, were 
layered on a Ficoll-H~aque ~ha~~ia) gradient. After 40 min cen- 
trifugation at 400 x g the interphase of peripheral blood mononuclear 
cells was collected, washed twice with PBS, and placed in plastic tissue 
culture flasks at a concentration of l-2 x lo6 cells/cm surface area. The 
cells were cultured in Iscove medium supplemented with 10% fetal calf 
serum, 2 mM glutamine, and 50 @ml of penicillin and streptomycin. 
After 3-4 h of incubation the non-adherent cells were washed out using 
PBS with Ca*+ and MgZ’. The adherent cells (monocytes) were next 
cultured overnight and then stimulated with human recombinant IFNy 
(Amersham) (50 U/ml). After established periods of time the cells were 
harvested for RNA extraction or protein isolation. The U937 cell line 
was grown in RPM1 1640 medium supplemented with 10% FCS, 2 mM 
glutamine, and 1% penicillin/streptomycin. These cells were differen- 
tiated into monocytes/macrop~ages by PMA (20 ngJml) for 3 days and 
stimulated with IFNy (100 U/ml) as described above for human mon- 
ocytes. 
2.2. RNA extraction and hybridization 
Following culture, the adherent cells were washed twice with PBS 
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and than guanidi~-lysed directly in the culture flasks for RNA extrac- 
tion using the procedure of Chomczynsky and Sacchi [ZZJ. 15 #g of total 
cellular RNA of each sample (as measured by AZM) absorption) were 
next electrophoresed in 1.2% agarose with 2.2 M formaldehyde in the 
presence of 0.5 pug of ethidium bromide and added directly to the 
sample. After electrophoresis the gel was capillary-blotted on to nitro- 
cellulose. ~ehybridization and hyb~d~tion were carried out at 42°C 
in a mixture containing 50% fo~a~de, 5 x SSC, 5 x Denhardt’s olu- 
tion, 20 mM sodium phosphate buffer, pH 6.5, and 100 pg of dena- 
tured, sheared salmon sperm DNA per ml. In the case of hybridization, 
the mixture was supplemented with 10% dextran sulfate and denatured 
probe. The cDNA probes; human ODC and IRF-1 (a 369 bp fragment 
obtained by RT-PCR from HL60 cells) were labeled by the random 
primer method to a mean specific activity of 0.5-1.3 x lo6 cpm&g 
DNA, Membrane were hyb~dized for 18-24 h and then washed twice 
with a mixture containing 2 x SSC and 0.2% sodium dodecyl sulfate 
(SDS) for 5 min at room temperature and 3 times with a mixture of 0.1 x 
SSC and 0.1% SDS for 30 ruin at 52°C. Membranes were exposed for 
2472 h at -80°C using intesifying screens. 
2.3. Protein extracts and gel-shift assay 
The nuclear protein extracts and gel shift assay were prepared by a 
modification of the protocol described by Schreiber et al. [23]. After the 
established times of culture the cells, typically 2 x 106, were washed 
twice with PBS and than harvested with a rubber policeman in 500 ~1 
cold buffer containing: 10 mM HEPES, pH 7.9, 10 mM KCl, 0.2 mM 
EDTA, 1 mM dithiotreitol, 0.5 mM PMSF, and 10 pg/rnl aprotinin. 
The homogenates were centrifuged for 30 s in a microcentrifuge at 
4°C. The nuclear pellets were resuspended in 50 ~1 of ice-cold buffer 
and the tubes were vigorously rocked at 4°C for 15 min. The buffer 
contained: 20 mM HEPES, pH 7.9,0.4 M NaCl, 0.2 mM EDTA, 1 mM 
dithiotreitol, 0.5 mM PMSF, and 10 &ml aprotinin. The nuclear 
extracts were centrifuged for 5 min at 4°C and the supernatants were 
frozen in aliquots at -80°C. The protein content was estimated with a 
kit for protein micr~ete~nation (Sigma Diagnostics). The 22 bp 
double-stranded oligonucleotide containing the binding sequence for 
the IRF-1 protein found in the non-coding region of the ODC gene, was 
labeled with terminal transferase and purified on a spin column accord- 
ing to the method described by Maniatis et al. [24]. Binding reactions 
were carried out by incubating the probe (0.3 ng; 30,000-40,000 cpm) 
with 10 ~1 of incubation buffer containing: 4% Ficoll, 20 mM HEPES, 
50 mM KCl, 0.2 mM EDTA, 1 mM dithiotreitol, 0.25 mglml BSA, 
8 &ml poly(dI-dC), and 5 lug of nuclear extract. In the gel-shift assay 
an unlabeled oligonucleotide containing a high affinity IRF-I binding 
sequence four times repeated (AAGTGA) and an unlabeled non-spe- 
cific oligonucleotide containing the binding sequence for the AP-1 com- 
plex were added in molar excess (500-100 X) for competition. After 30 
min of incubation at room temperature, samples were electrophoresed 
through a 4% polyac~lamide gel for 1.5 hat 120 V. Prior to electropho- 
resis 0.01% Bromophenol blue was added to the samples. Gels were 
exposed to X-ray film with intensifying screens for 2448 h. 
3. Results and discussion 
Monocytes/macrophages play a central role in im- 
mune and inflammatory responses, Macrophages can be 
activated by endogenous cytokines such as interferons, 
granulocyte-macrophage colony stimulating factor, and 
tumor necrosis factor, as well as exogenous factors such 
as lipopolysaccharide. When macrophages are activated, 
(a) 5’ GGAACTGAAACT 3’ 
(b) 5’ G(A)A~(G/C)~/C)G~A(G/C)~/C) 3’ 
Fig. 1. (a) IRF-1 binding sequence in the first intron of the ODC gene. 
(b) IRF-1 consensus binding sequence. 
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Fig. 2. Effect of IFNy on accumulation of IRF-1 mRNA in human 
macrophages. 
they carry out a number of important immune functions, 
including the presentation of antigens, phagocytosis, and 
the killing of microbial and tumor cells. IFNy is a key 
lymphokine in macrophage activation. IFNy-mediated 
activation causes the induction of specific genes [25-281; 
for instance, there are many data available indicating the 
role of ODC [29-311. Rapid accumulation of ODC 
mRNA has been associated with a stimulaton of a ple- 
thora of physiological responses, suggesting that the 
ODC gene may be involved in the phenomenon of cell 
activation; in fact, activation of ODC expression has 
been repeatedly linked to the stimulation of cell prolifer- 
ation and induction of differentiation. The intra~llular 
availability of ODC is controlled at multiple levels, in- 
cluding both transcription-dependent and -independent 
mechanisms, translation, protein stability, and en- 
dogenous inhibition of its enzymatic activity [32,33]. In 
this report we studied the gene expression of IRF-1 in 
human macrophage cells upon IFNy activation and we 
addressed the question of whether it regulates ODC gene 
expression. In fact, we found a binding sequence for 
IRF-1 in the first intron (non-coding region) of the ODC 
gene. To demonstrate that the transcription factor IRF-1 
is involved in the monocyte/macrophage IFNy activa- 
tion signal transduction pathway we first checked the 
expression of IRF- 1 in IFNy-activated human macroph- 
ages and monocytes/macrophages of differentiated U937 
cells for 0, 30 min, 2 h, 8 , and 24 h. After RNA extrac- 
tion Northern blot assays were performed and the nylon 
filters were hybridized with IRF-I cDNA probe (Figs. 
2,3). These figures show that IFNy causes an accumula- 
tion of IRF-1 mRNA after 2 h of stimulation. To dem- 
onstrate the functional role of IRF-1 on ODC gene ex- 
- + 0 05 2 8 24 
Fig. 3. Effect of IFNy on accumulation of mRNA in human U937 cell 
line after PMA differentiation. 
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Fig. 4 (A) IRF-1 mRNA levels in tk-ts13 cells transfected with SV-IRF-1 plasmid (lane 2) and with the empty SV40 control plasmid (lane 1); 
(B) ODC mRNA levels in tk-ts13 cells transfected with SV-IRF-1 plasmid (lane 4) and with the empty SV40 control plasmid (lane 3); (C) control 
rRNA ethidium bromide bands. 
pression, we cotransfected a hamster fibroblast cell line, tested the IRF-1 expression in a mixed population of 
tk-ts13 (timidine kinase-lacking ene), with the SV-IRF- colonies transfected with IRF-1 (Fig. 4A, lane 2) com- 
1 plasmid containing the full-length IRF- 1 cDNA under pared with colonies transfected with the empty SV40 
the control of the SV40 promoter and with the plltk plasmid as a control (Fig. 4A, lane 1). We than checked 
plasmid containing the timidine kinase gene. Positive the expression of ODC and found that the cells that 
colonies were selected in medium containing gHAt. After constitutively express IRF-1 over-express the ODC gene 
the stable integration of IRF- 1 in the cellular genome we (Fig. 4B, lane 4). To demonstrate the direct interaction 
1 2 34567 8 9 10 
specific complex 
Fig. 5. Gel retardation analysis of the 32P-labeled 20 bp oligonucleotide containing the binding sequence for IRF-1 incubated with nuclear extracts 
from human macrophages and U937 cells (differentiated in macrophages by PMA) stimulated with IFNy for 2 h, and from K562 cells activated with 
IFNy for 2 h as a positive control. Lanes: (1) free probe. Probe incubated with: (2) nuclear extracts from K562 cells; (3) K562 nuclear extracts and 
the specific competitor; (4) U937 nuclear extracts; (5) U937 nuclear extracts and the specific competitor; (6) macrophage nuclear extracts; 
(7) macrophage nuclear extracts and the specific competitor; (8) K562 nuclear extracts and the aspecific ompetitor; (9) U937 nuclear extracts and 
the aspecific competitor; (10) macrophage nuclear extracts and the aspecific competitor. 
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between IRF-1 and the ODC gene, a 20 bp double- 
stranded 32P-labeled oligonucleotide containing the con- 
sensus binding sequence for IRF-1 found in the ODC 
gene was reacted with nuclear proteins extracted from 
human macrophages and from U937 cells treated with 
PMA activated by IFNy for 2 h, the time at which there 
is a high expression of IRF-1 (Fig. 5). A specific com- 
plex was detected (Fig. 5, lanes 2,4,6); this complex dis- 
appeared when a 24 bp double-stranded unlabeled oli- 
gomer containing a high affinity IRF-1 binding examer 
repeated four times (AAGTGA),, was added in molar 
excess as a competitor (Fig. 5, lanes 3,5,7). Moreover, the 
complex was still present after competition with a dou- 
ble-stranded aspecific competitor (Fig. 5, lanes 8,9,10). 
From our results it is clear that the transcription factor 
IRF-1 binds to the first intron of the ODC gene and 
transactivates the transcription of this gene. In order to 
better establish the functional role of IRF-1 in the regu- 
lation of ODC gene expression in human macrophages 
activated by IFNy other studies are being carried out. 
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